AAAAAA

   
Results: 1-12 |
Results: 12
PREVALENT VERTEBRAL FRACTURES PREDICT HOSPITALIZATION AND MORTALITY IN OLDER WOMEN - THE FRACTURE INTERVENTION TRIAL (FIT)
Authors: ENSRUD K THOMPSON D NEVITT M HOCHBERG M SANTORA A BLACK DM
Citation: K. Ensrud et al., PREVALENT VERTEBRAL FRACTURES PREDICT HOSPITALIZATION AND MORTALITY IN OLDER WOMEN - THE FRACTURE INTERVENTION TRIAL (FIT), Arthritis and rheumatism, 41(9), 1998, pp. 1634-1634
5-YEAR TREATMENT OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN WITH ORAL ALENDRONATE - EFFECTS ON BONE MASS AND TURNOVER AND SAFETY
Authors: FAVUS M EMKEY R LEITE M DEVOGELAER JP RODRIGUEZ J PEVERLY C KAUR A SANTORA A
Citation: M. Favus et al., 5-YEAR TREATMENT OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN WITH ORAL ALENDRONATE - EFFECTS ON BONE MASS AND TURNOVER AND SAFETY, Journal of bone and mineral research, 12, 1997, pp. 189-189
BIOCHEMICAL MARKERS PREDICT SPINE BUT NOT HIP BMD RESPONSE TO ALENDRONATE - THE FRACTURE INTERVENTION TRIAL (FIT)
Authors: BAUER DC BLACK DM OTT SM SANTORA A THOMPSON D ENNIS M CUMMINGS SR
Citation: Dc. Bauer et al., BIOCHEMICAL MARKERS PREDICT SPINE BUT NOT HIP BMD RESPONSE TO ALENDRONATE - THE FRACTURE INTERVENTION TRIAL (FIT), Journal of bone and mineral research, 12, 1997, pp. 190-190
CLINICAL UTILITY OF SKELETAL ALKALINE-PHOSPHATASE (SALP) (TANDEM(R)-ROSTASE(R)) IN MONITORING INDIVIDUAL POSTMENOPAUSAL OSTEOPOROTIC WOMENUNDERGOING ALENDRONATE (ALN) THERAPY
Authors: MIZRAHI L ARMOUR K EMKEY R MARCUS R SANTORA A KRESS B
Citation: L. Mizrahi et al., CLINICAL UTILITY OF SKELETAL ALKALINE-PHOSPHATASE (SALP) (TANDEM(R)-ROSTASE(R)) IN MONITORING INDIVIDUAL POSTMENOPAUSAL OSTEOPOROTIC WOMENUNDERGOING ALENDRONATE (ALN) THERAPY, Journal of bone and mineral research, 12, 1997, pp. 460-460
THE EFFECTS OF ORAL ALENDRONATE ON BONE MASS AND TURNOVER AND SAFETY - 5-YEAR TREATMENT OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN
Authors: EMKEY R MCILWAIN H FAVUS M LEITE M DEVOGELAER JP RODRIGUEZ J PEVERLY C ARNOLD A KAUR A SANTORA A
Citation: R. Emkey et al., THE EFFECTS OF ORAL ALENDRONATE ON BONE MASS AND TURNOVER AND SAFETY - 5-YEAR TREATMENT OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN, Arthritis and rheumatism, 40(9), 1997, pp. 626-626
BIOCHEMICAL MARKERS PREDICT SPINE BUT NOT HIP BMD RESPONSE TO ALENDRONATE - THE FRACTURE INTERVENTION TRIAL (FIT)
Authors: BAUER DC BLACK DM OTT SM SANTORA A THOMPSON D ENNIS M CUMMINGS SR
Citation: Dc. Bauer et al., BIOCHEMICAL MARKERS PREDICT SPINE BUT NOT HIP BMD RESPONSE TO ALENDRONATE - THE FRACTURE INTERVENTION TRIAL (FIT), Arthritis and rheumatism, 40(9), 1997, pp. 1479-1479
CLINICAL UTILITY OF BONE SPECIFIC ALKALINE-PHOSPHATASE (BAP) (TANDEM(R)-R OSTASE(TM)) IN MONITORING INDIVIDUAL POSTMENOPAUSAL OSTEOPOROTIC WOMEN UNDERGOING ALENDRONATE (ALN) THERAPY
Authors: MIZRAHI I ARMOUR K EMKEY R MARCUS R SANTORA A KRESS B
Citation: I. Mizrahi et al., CLINICAL UTILITY OF BONE SPECIFIC ALKALINE-PHOSPHATASE (BAP) (TANDEM(R)-R OSTASE(TM)) IN MONITORING INDIVIDUAL POSTMENOPAUSAL OSTEOPOROTIC WOMEN UNDERGOING ALENDRONATE (ALN) THERAPY, Arthritis and rheumatism, 39(9), 1996, pp. 359-359
3-YEAR TREATMENT OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN WITH ORAL ALENDRONATE - EFFECTS ON BONE MASS AND TURNOVER AND SAFETY
Authors: DOWNS R BAKER M BELL N EMKEY R TONINO R TUCCI J WEISS S PEVERLY C KHER U SANTORA A
Citation: R. Downs et al., 3-YEAR TREATMENT OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN WITH ORAL ALENDRONATE - EFFECTS ON BONE MASS AND TURNOVER AND SAFETY, Journal of bone and mineral research, 10, 1995, pp. 139-139
RESOLUTION OF ALENDRONATE EFFECTS ON BONE TURNOVER AND BMD AFTER MULTIYEAR TREATMENT OF OSTEOPOROTIC WOMEN
Authors: STOCK J BELL N CHESNUT C ENSRUD K GENANT H HARRIS S MCCLUNG M SINGER F YOOD R PRYORTILLOTSON S WEI L SANTORA A
Citation: J. Stock et al., RESOLUTION OF ALENDRONATE EFFECTS ON BONE TURNOVER AND BMD AFTER MULTIYEAR TREATMENT OF OSTEOPOROTIC WOMEN, Journal of bone and mineral research, 10, 1995, pp. 197-197
EFFICACY OF ALENDRONATE TO INCREASE BMD IS SIMILAR IRRESPECTIVE OF BASE-LINE BONE TURNOVER, BMD AND AGE
Authors: HIRSCH L WATTS N MCILWAIN H RODRIQUEZ J ROMANOWICZ A DAIFOTIS A KHER U SANTORA A
Citation: L. Hirsch et al., EFFICACY OF ALENDRONATE TO INCREASE BMD IS SIMILAR IRRESPECTIVE OF BASE-LINE BONE TURNOVER, BMD AND AGE, Journal of bone and mineral research, 10, 1995, pp. 350-350
PROGRESSIVENESS AND GENERALIZABILITY OF THE EFFECTS OF ALENDRONATE ONBONE MASS AND SAFETY EXPERIENCE IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS
Authors: EMKEY R CORREAROTTER R SANTORA A LOMBARDI A DAIFOTIS A
Citation: R. Emkey et al., PROGRESSIVENESS AND GENERALIZABILITY OF THE EFFECTS OF ALENDRONATE ONBONE MASS AND SAFETY EXPERIENCE IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS, Arthritis and rheumatism, 38(9), 1995, pp. 1239-1239
CONFIRMATION OF INTERNAL JUGULAR-VEIN CANNULATION - THE FINUCANE TECHNIQUE
Authors: ARNDT GA FELTON T FINUCANE B SANTORA A
Citation: Ga. Arndt et al., CONFIRMATION OF INTERNAL JUGULAR-VEIN CANNULATION - THE FINUCANE TECHNIQUE, Canadian journal of anaesthesia, 40(12), 1993, pp. 1220-1221
Risultati: 1-12 |